We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 16

ACCC issues report on private health insurance

  • Gilbert + Tobin
  • -
  • Australia
  • -
  • March 31 2013

The ACCC report on 'anti-competitive and other practices by health funds and providers in relation to private health insurance' has been tabled in

GPs given a clean bill of health to engage in price setting

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 18 2013

The ACCC has granted authorisation to individual General Practitioners (GPs) working in shared practices to allow them to engage in intra-practice

ACCC proposes to allow GPs to set practice prices

  • Gilbert + Tobin
  • -
  • Australia
  • -
  • February 28 2013

In response to an application lodged by the Australian Medical Association, the ACCC proposes to allow GPs in single practices to set practice prices

Interim authorisation granted to eRx script

  • Gilbert + Tobin
  • -
  • Australia
  • -
  • February 28 2013

The ACCC granted interim authorisation to eRx Script Exchange to allow it to enter into a contract with MediSecure to facilitate interoperability

ACCC conditionally clears NestlePfizer deal

  • Herbert Smith Freehills LLP
  • -
  • Australia
  • -
  • November 30 2012

On 22 November 2012, the Australian Competition and Consumer Commission (ACCC) announced it would not oppose the proposal by Nestlé SA to acquire the global infant nutrition business of Pfizer Inc (the transaction), subject to court enforceable undertakings

Those drugs cost how much?? Chemist warehouse price list misleading but not for the reasons you might think

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • October 29 2012

Last Monday the Supreme Court of Queensland held that a price list published by various Chemist Warehouse pharmacies in Cairns, Nerang, Coolangatta and other parts of Queensland was likely to mislead or deceive and therefore contravene clause 18 of the Australian Consumer Law (Competition and Consumer Act 2010 (Cth), schedule 2, section 18

Managing your risks under global anti-corruption regimes

  • Piper Alderman
  • -
  • Australia, United Kingdom, USA
  • -
  • September 13 2012

Pharmaceutical and medical device companies operate in a stringent regulatory environment

Collective bargaining

  • Gilbert + Tobin
  • -
  • Australia
  • -
  • August 22 2012

The ACCC proposes to allow St Vincent’s Private Hospital Sydney to join other members of the St Vincent’s Health Australia Group (these other members being related bodies corporate) in the collective and joint activity of the group, effectively enabling them to operate as a single economic entity

European Commission ups the cost of paying for delay

  • King & Wood Mallesons
  • -
  • Australia, European Union, USA
  • -
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

ACCC authorises potential cartel conduct by private health funds

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • November 3 2011

On 25 August 2011, the ACCC issued a final determination granting authorisation for a management services agreement between two private health funds, the Reserve Bank Health Society and Lysaght Peoplecare Limited

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy